编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
---|---|---|---|---|
L20345 | Prexasertib free base | 1234015-52-1 | 98% Min. | ![]() |
Prexasertib, also know LY2606368, is a n inhibitor of checkpoint kinase 1 (chk1) with | ||||
L20333 | Parsaclisib HCl | 1995889-48-9 | 98% Min. | ![]() |
Parsaclisib, also known as INCB050465, is a novel PI3Kδ inhibitor which synergizes w | ||||
L20332 | Parsaclisib free base | 1426698-88-5 | 98% Min. | ![]() |
Parsaclisib, also known as INCB050465, is a novel PI3Kδ inhibitor which synergizes w | ||||
20294 | Paltusotine ( CRN-00808 ) | 2172870-89-0 | ≧98.0% | ![]() |
Paltusotine 是一类新型的、口服、选择性、非肽类2型生长抑素受体 | ||||
20282 | PS210 | 1221962-86-2 | 98% Min. | ![]() |
PS210 is a substrate-selective inhibitor of protein kinase PDK1. It acts by binding t | ||||
20278 | PD-159206 | 171744-42-6 | ≧94.0% | ![]() |
PD-159206 is a nucleocapsid inhibitor. It exhibits good antiviral activity against HI | ||||
21227 | 3PO | 18550-98-6 | 98% Min. | ![]() |
3PO is a PFKFB3 (6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase) inhibitor. 3PO | ||||
2073108 | PF-06802861 ( ARRY 371797 ; ARRY-797 ) | 1034189-82-6 | ≧98.0% | ![]() |
ARRY 797(也称为ARRY 371797或PF 06802861)是一种具有口服活性,选择性 | ||||
2071623 | PF-04745637 | 1917294-46-2 | 98% Min. | ![]() |
PF-04745637 is a TRPV1 antagonist. | ||||
2071607 | Pepstatin | 26305-03-3 | 98% Min. | ![]() |
Pepstatin inhibits the aspartic protease endothiapepsin. | ||||
2071540 | PF-477736 | 952021-60-2 | 98% Min. | ![]() |
PF-477736, also known as PF-00477736, is a potent CHK1 inhibitor with potential chemo | ||||
2071506 | PF-06869206 | 2227425-05-8 | 98% Min. | ![]() |
PF-06869206 is an Orally Bioavailable Selective Inhibitors of the Sodium-Phosphate Co | ||||
2071401 | Pimodivir ( VX-787 ) | 1629869-44-8 | 98% Min. | ![]() |
Pimodivir (VX-787) 是一种可口服的甲型流感病毒聚合酶抑制剂,通过 | ||||
2062201 | p-Aminophenol sulfate | 85278-22-4 | 98% Min. | |
2062020 | 3-PHENYL-1H-PYRAZOLE-4-CARBALDEHYDE | 26033-20-5 | 96% Min. | ![]() |
2061707 | Preladenant | 377727-87-2 | 98% Min. | ![]() |
Preladenant, also known as SCH 420814, is a potent and selective antagonist at the ad | ||||
2061706 | Paquinimod | 248282-01-1 | 98% Min. | ![]() |
Paquinimod, also known as ABR‑215757, is a S100A9 inhibitor preventing S100A9 bindi | ||||
2061301 | PDM-2 | 688348-25-6 | 98% Min. | ![]() |
PDM-2 is an analog of resveratrol acting as a potent and selective aryl hydrocarbon r | ||||
206701 | PU-WS13 | 1454619-14-7 | 98% Min. | ![]() |
PU-WS13 is a potent, Grp94-specific Hsp90 inhibitor of the purine scaffold class. PU- | ||||
S-204148 | 吡啶-2,6-二甲醛 | 5431-44-7 | 98% Min. | ![]() |
S-204141 | 1-((1aR,6r,10bS)-1,1-二氟-1,1a,6,10b-四氢二苯并[a,e]环丙[c][7]环壬-6-基)哌嗪盐酸盐 | 312905-21-8 | 96% Min. | ![]() |
193282 | PZ-2891 | 2170608-82-7 | >98% | ![]() |
PZ-2891是一种强效的、选择性的、口服活性泛酸激酶(PANK)调制剂, | ||||
193264 | PF-06835919 ( MDK-1846 ) | 2102501-84-6 | ≧98.0% | ![]() |
MDK1846是一种强效的酮己糖激酶(KHK)抑制剂。 | ||||
31619 | PTI-428(PTI428) | 1953130-87-4 | 98% Min. | ![]() |
PTI-428是一种研究性CFTR放大器,开发用于治疗CFTR基因中发生F508del | ||||
1932011 | PF-05085727 | 1415637-72-7 | >98% | ![]() |
PF-05085727是一种强效、选择性和脑穿透性磷酸二酯酶2A抑制剂。 | ||||
193206 | Petesicatib | 1252637-35-6 | >98% | ![]() |
Petesicatib是一种组织蛋白酶抑制剂的候选药物。 | ||||
193204 | Pyridone 6 | 457081-03-7 | >98% | ![]() |
吡啶酮6,也被称为CMP 6或JAK抑制剂I,是一种pan-janus-激活的激酶抑 | ||||
193110 | Pretomanid | 187235-37-6 | >98% | ![]() |
Pretomanid,也被称为PA-824,一种生物还原药物。PA-824具有较强的体 | ||||
192282 | PF-4136309 | 1341224-83-6 | >98% | ![]() |
PF-4136309,又称INCB8761,是一种口服的人趋化因子受体2 (CCR2)拮抗剂 | ||||
192272 | 帕利伐米 | 31645-39-3 | >98% | ![]() |
帕利伐米,又名ZIO201,是一种具有潜在抗肿瘤活性的合成芥菜化合 |